LEO, Eliana Grazia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.229
AS - Asia 9.139
EU - Europa 8.235
SA - Sud America 1.314
AF - Africa 198
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 16
Totale 36.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.894
SG - Singapore 2.658
GB - Regno Unito 2.585
CN - Cina 2.503
IT - Italia 1.835
HK - Hong Kong 1.060
VN - Vietnam 1.056
SE - Svezia 1.039
BR - Brasile 1.025
DE - Germania 637
FR - Francia 369
FI - Finlandia 360
UA - Ucraina 360
BD - Bangladesh 356
RU - Federazione Russa 351
KR - Corea 307
TR - Turchia 278
IN - India 260
CA - Canada 166
BG - Bulgaria 151
AR - Argentina 110
NL - Olanda 104
ID - Indonesia 98
MX - Messico 89
JP - Giappone 82
BE - Belgio 76
IQ - Iraq 70
ZA - Sudafrica 61
PL - Polonia 54
ES - Italia 49
AE - Emirati Arabi Uniti 46
PK - Pakistan 46
IR - Iran 44
EC - Ecuador 41
IE - Irlanda 41
PH - Filippine 38
AU - Australia 37
CO - Colombia 37
LT - Lituania 34
CL - Cile 33
MA - Marocco 32
RO - Romania 28
CH - Svizzera 24
MY - Malesia 24
CZ - Repubblica Ceca 23
TW - Taiwan 23
UZ - Uzbekistan 23
KE - Kenya 22
VE - Venezuela 22
EG - Egitto 21
PY - Paraguay 19
TH - Thailandia 19
TN - Tunisia 18
AZ - Azerbaigian 17
NP - Nepal 17
JO - Giordania 16
SA - Arabia Saudita 16
IL - Israele 15
PT - Portogallo 15
AT - Austria 14
NZ - Nuova Zelanda 14
PA - Panama 14
DZ - Algeria 13
PE - Perù 13
GR - Grecia 12
JM - Giamaica 12
EU - Europa 10
KZ - Kazakistan 10
DK - Danimarca 9
RS - Serbia 9
CR - Costa Rica 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
LK - Sri Lanka 7
PS - Palestinian Territory 7
BY - Bielorussia 6
EE - Estonia 6
GT - Guatemala 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
KG - Kirghizistan 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
HN - Honduras 4
HR - Croazia 4
KW - Kuwait 4
MN - Mongolia 4
NG - Nigeria 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
Totale 36.129
Salva come PNG Salva come JPEG
Città #
Southend 1.754
Singapore 1.718
Santa Clara 1.701
Ashburn 1.508
Fairfield 1.242
Chandler 1.067
Hong Kong 1.031
Woodbridge 944
Hefei 798
Jacksonville 711
Houston 691
San Jose 644
Dearborn 572
Nyköping 523
Ann Arbor 521
Wilmington 506
Beijing 471
Seattle 468
Cambridge 428
London 368
Los Angeles 346
Ho Chi Minh City 333
Chicago 332
Council Bluffs 297
Modena 282
Hanoi 270
Seoul 268
The Dalles 247
Helsinki 225
New York 192
Milan 160
Izmir 152
Princeton 149
Sofia 141
Eugene 126
Lauterbourg 126
Salt Lake City 122
San Diego 119
Moscow 109
Buffalo 106
Dallas 98
Bremen 94
Shanghai 84
São Paulo 81
Redwood City 73
Frankfurt am Main 70
Rome 68
Tampa 63
Da Nang 61
Fremont 61
Munich 59
Columbus 58
Orem 57
Tokyo 56
Brussels 55
Des Moines 51
Bologna 46
Elk Grove Village 46
Jakarta 45
Warsaw 43
Ottawa 36
Guangzhou 35
Dublin 34
Mexico City 34
Atlanta 33
Rio de Janeiro 33
Boardman 32
Mumbai 32
Washington 32
Chennai 31
Falls Church 31
Haiphong 31
Lancaster 31
Denver 30
Johannesburg 30
Toronto 30
Montreal 29
Nanjing 29
Naples 29
San Francisco 29
Amsterdam 28
Phoenix 28
Belo Horizonte 27
Kent 25
New Delhi 25
Baghdad 24
Miami 24
Miano 24
Parma 23
Porto Alegre 23
Brooklyn 22
Kunming 22
San Mateo 22
Dhaka 21
Detroit 20
Napoli 20
Tashkent 20
Quito 19
Stockholm 19
Basingstoke 18
Totale 24.122
Salva come PNG Salva come JPEG
Nome #
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 466
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 456
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 431
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 410
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 397
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 394
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 379
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 379
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 376
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 371
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 370
Bead coating process via an excess of crosslinking agent 360
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 354
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 348
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 348
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 346
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 344
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 343
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 339
Chitosan-alginate microparticles as a protein carrier 336
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 335
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 332
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 329
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 327
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 326
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 318
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 315
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 312
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 309
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 308
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 308
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 300
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 299
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 297
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 296
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 294
Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles 293
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 292
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 287
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 284
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 283
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 283
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 281
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 279
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 278
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 278
Protein immobilization in crosslinked alginate microparticles 275
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 271
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 271
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 268
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 268
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 268
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 267
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 265
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 264
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 259
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 254
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 252
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 251
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 251
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 249
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 249
Caratterizzazione chimico-fisica di membrane e feltri di collagene 249
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 245
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 244
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 243
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 241
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 240
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 240
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 239
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 236
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 235
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 234
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 234
Modified PLGA Nanoparticles as drug carriers for CNS delivery 232
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 232
Surface drug removal from ibuprofen-loaded PLA microspheres 231
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 229
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 226
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 226
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 224
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 223
Caratterizzazione chimico-fisica e studi di stabilità di sistemi lipidici per il transfer genico 222
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 222
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres 220
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 219
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 218
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 214
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 214
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 212
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 212
Development of new formulations of cationic solid lipid nanoparticles (SLNs) for the drug delivery to the brain 211
In vitro behaviour of multicomposite cationic SLN as new platform for pDNA delivery 211
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 210
Formulazione per veicolare principi attivi lipofili 209
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 202
The influence of 2-hydroxypropyl-beta-cyclodextrin on the haemolysis induced by bile acids 200
Drug release from perforated matrices containing hydroxypropylcellulose 200
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoprecipitation method 196
Totale 28.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.990
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/20222.585 63 304 233 158 86 174 125 134 314 196 510 288
2022/20232.985 464 350 212 326 337 419 56 243 332 48 113 85
2023/20241.624 77 117 129 161 340 176 161 160 46 38 78 141
2024/20256.582 272 71 187 432 1.203 796 543 499 670 243 748 918
2025/202611.987 780 504 949 1.330 1.817 797 1.487 666 1.290 1.200 654 513
Totale 36.479